Order Article Reprints

Silva DF, Reis LES, Machado MGC, Dophine DD, de Andrade VR, de Lima WG, Andrade MS, Vilela JMC, Reis AB, Pound-Lana G, et al. Repositioning of Tamoxifen in Surface-Modified Nanocapsules as a Promising Oral Treatment for Visceral Leishmaniasis. Pharmaceutics. 2021; 13(7):1061. https://doi.org/10.3390/pharmaceutics13071061

Silva, Débora Faria, Levi Eduardo Soares Reis, Marina Guimarães Carvalho Machado, Douglas Daniel Dophine, Vinicius Roberto de Andrade, Wanderson Geraldo de Lima, Margareth Spangler Andrade, José Mário Carneiro Vilela, Alexandre Barbosa Reis, Gwenaelle Pound-Lana, and et al. 2021. "Repositioning of Tamoxifen in Surface-Modified Nanocapsules as a Promising Oral Treatment for Visceral Leishmaniasis" Pharmaceutics 13, no. 7: 1061. https://doi.org/10.3390/pharmaceutics13071061

Silva, D. F., Reis, L. E. S., Machado, M. G. C., Dophine, D. D., de Andrade, V. R., de Lima, W. G., Andrade, M. S., Vilela, J. M. C., Reis, A. B., Pound-Lana, G., Rezende, S. A., & Mosqueira, V. C. F. (2021). Repositioning of Tamoxifen in Surface-Modified Nanocapsules as a Promising Oral Treatment for Visceral Leishmaniasis. Pharmaceutics, 13(7), 1061. https://doi.org/10.3390/pharmaceutics13071061